|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Frovatriptan#Contraindications]] |
| {{Frovatriptan}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Contraindications==
| |
| | |
| FROVA is contraindicated in patients with:
| |
| | |
| *Ischemic coronary artery disease (CAD) (e.g. angina pectoris, history of [[myocardial infarction]], or documented silent ischemia), or coronary artery vasospasm, including Prinzmetal’s[[ angina]] [see Warnings and Precautions (5.1)].
| |
| | |
| *Wolff-Parkinson-White Syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorders [see Warnings and Precautions (5.2)].
| |
| | |
| *History of stroke, [[transient ischemic attack]] ([[TIA]]), or history of hemiplegic or basilar [[migraine]] because these patients are at a higher risk of stroke [see Warnings and Precautions (5.4)].
| |
| | |
| *Peripheral vascular disease [see Warnings and Precautions (5.5)].
| |
| | |
| *Ischemic bowel disease [see Warnings and Precautions (5.5)].
| |
| | |
| *Uncontrolled [[hypertension]] [see Warnings and Precautions (5.8)].
| |
| | |
| *Recent use (i.e., within 24 hours) of another 5-HT1 agonist, an [[ergotamine]] containing or ergot-type medication such as [[dihydroergotamine]] ([[DHE]]) or [[methysergide]] [see Drug Interactions (7.1, 7.2)].
| |
| | |
| *[[Hypersensitivity]] to FROVA (angioedema and anaphylaxis seen) [see Warnings and Precautions (5.9)].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = FROVA (FROVATRIPTAN SUCCINATE) TABLET, FILM COATED [ENDO PHARMACEUTICALS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0703630-9ce8-4259-841e-71fd2019fa66 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Antimigraine drugs]]
| |
| [[Category:Triptans]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |